Activation of protein kinase C down-regulates IFN-gamma receptors

Activation of protein kinase C down-regulates IFN-gamma receptors

Vol. 144, No. 1, 1987 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 337-344 April 14, 1987 ACTIVATION OF PROTEIN KINASE C D O W N - R ...

415KB Sizes 8 Downloads 125 Views

Vol. 144, No. 1, 1987

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 337-344

April 14, 1987

ACTIVATION

OF PROTEIN KINASE C D O W N - R E G U L A T E S

Antonella Fassio, Franca Cofano, Giorgio Cavallo,

IFN-GAMMA RECEPTORS

and Santo Landolfo

Department of Microbiology, Medical School, University of Torino, 10126 - Torino, Italy Received January 19, 1987

SUMMARY: Treatment of mouse EL-4 cells with intracellular activators of protein kinase C, namely 4 -phorbol 12-myristate 13-acetate (PMA) and diacylglycerol, resulted in 90% reduction in cell surface interferon-gamma (IFN-gamma) receptors as judged by iodinated-IFN-gamma binding. This did not seem to be due to a decreased in the receptor affinity, since that of the remaining surface receptors appeared to be singnificantly increased as shown in Scatchard plot analysis. Kinetics experiments revealed that a PMA treatment as short as 15 min was sufficient to induce a decrease of 30% of IFN-gamma receptors, whereas the highest levels of down-regulation were observed after 60-90 min. Treatment of EL-4 cells with calcium ionophore, A23187, although ineffective by itself, dramatically increased the ability of suboptimal P M A concentrations to mediate IFN-gamma receptor down-regulation. Finally, specificity studies revealed that P M A is particularly effective in decreasing the binding of IFN-gamma to T-iymphocytes. Altogether these results suggest a possible involvement of protein kinase C in the regulation of IFN-gamma receptor expression. © 1987AcaaemicPress, lnc.

Phorbol esters, tetracyclic diterpenes, are potent tumor promoting agents

that

appear

to

specific

exert pleiotropic effects on cells (1,2). Their be

mediated

intracellular

receptor,

diacylglycerol-activated, been

shown

that

(5,6). Directly

finding

that

protein

activation

of

the

Ca2+/phospholipid-dependent kinase C (3,4). Recently,

1,2-diacylglycerol,

phosphatidylinositol C

through the binding and

effects

a

product

of

it

has

the

metabolism, can also activate the protein kinase

related to the activation of this e n z y m e

is

the

PMA and 1,2-diacylglycerol can affect the expression of

Address correspondence to: Dr. Santo Landolfo, Istituto di Microbiologia, Via Santena 9, lO126-Torino, Italy. Abbreviations used in this paper: IFN-gammma, interferon-gamma; PMA, 4 ~-phorbol 12-myristate 13-acetate- diC 8. 1,2-Dioctanoyl-glycerol; BSA: bovine serum aibumin." 0006-291X/87 $1.50 337

Copyright © 1987 by Academic Press, Inc. All rights of reproduction in any form reserved.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Vol. 144, No. 1,1987

a

variety

of

membrane

down-regulation

receptors by either up-regulation

(7)

or

(8-10).

IFN-gamma, produced by T-lymphocytes

on stimulation with antigens

(II), modulates cell activity by activating genes coding for a number of

enzymes,

as yet poorly characterized , and also by enhancing

synthesis

of cell surface components

IFN-gamma

must

cells

(ii). To achieve these

interact with specific membrane

(12,13). Although

the

initial

effects,

receptors

physicochemical

the

on

target

interaction

between IFN-gamma and its receptor has now been characterized, nothing is

known

concerning the pathway of signalling transmission from

the

receptor to the intracellular environment. In this study, we present evidence that activation kinase

C

by

ionophore,

A23187,

receptors.

These

itself

1,2-Dioctanoyl-glycerol

PMA,

down-regulates results,

down-regulates

transmembrane

its

signalling

phospho-transferase

(diC8)

the expression

of

coupled with the finding own

receptors,

apparatus

suggest

involving

a

of and

calcium

the

IFN-gamma

that a

protein

IFN-gamma

common

unique

system. MATERIALS

AND METHODS

Cells. The murine cell lines used, EL-4 and L1210, were maintained in RPMI-1640 medium supplemented with 10% FCS. To analyze the effects of protein kinase C activators, cells were resuspended at 5 x 106/ml and incubated with increasing concentrations for different times. Chemicals. PMA, 1,2-Dioctanoyl-glycerol (diC8) and calcium ion0phore A23187 were purchased from Sigma Chemical C o m p a n y (St. Louis, Mo). Iodination of IFN-qamma. E. co/i-derived recombinant MuIFN-gamma with a specific activity of 1.5 x 107U/rag of protein was kindly provided by Dr. E. Adolf, Boehringer, Ingelheim (Vienna, Austria). Thirty micrograms of MuIFN-gamma were reacted for 2 hours at 4°C with 1 mCi of l~25I-Bolton-Hunter reagent ( < 2000 Ci/mmol)(Amersham, England) in 0.25 ml of sodium borate buffer, pH 8.0, as previously described (12). The reaction was stopped by addition of glycine at a final concentration of 0.2M and the mixture applied to a 20 x 0.6 cm column of Sephadex G-lO equilibrated with phosphate-buffered saline, 0.5M NaCl, pH 7.4, containing 0.2% bovine serum albumin (BSA). The fractions containing 125I-IFN-gamma were pooled, tested for antiviral activity and stored at 4° C. The specific radioactivity of the labeled IFN ranged from 30 to 40 uCi/ug. The overall recovery of antiviral activity was greater than 80%. Competition bindinq assay.s. Cells from exponetially growing cultures, resuspended at 2 x I0 ~ cells in 0.5 ml of RPMI-1640 medium

338

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Vol, 144, No. 1 , 1 9 8 7

supplemented with 0.2% BSA, w e r e incubated for 2 h o u r s at 23°C with constant amounts of 1 2 5 I - I F N - g a m m a a n d increasing concentrations of unlabeled IFN-gamma. Nonspecific linear binding was determined by simultaneous addition of a 500-fold e x c e s s of unlabeled IFN-gamma. After 120 min incubation at 23°C the cells were w a s h e d four times a n d the pellets c o u n t e d for cell-bound radioactivity. Nonspecific binding, n e v e r e x c e e d i n g 15% of total counts at saturation, was subtracted from total counts for determining specific binding.

RESULTS AND DISCUSSION The initial event during I F N - g a m m a represented Although

by

the

determined

and target cell interaction is

its binding to a specific m e m b r a n e

primary

structure

receptor

of m u r i n e I F N - g a m m a

from nucleotide s e q u e n c e s

has

known

about

the

now

obtained from c D N A clones

a n d that of its receptor has n o w partially characterized is

(12,13).

biochemical

signal

been (14),

(13), nothing

transduction

in

the

intracellular compartment. In IFN-gamma

order

to a n a l y z e the effect of P M A

the

expression

doses

of P M A for 2 h at 37°C. As s h o w n in Fig. I,

as

low

as

IO-9M resulted in

25-30%

loss

treatment of

surface

IFN-gamma

receptor, as a s s e s s e d by c o m p a r i s o n with untreated

cells.

higher

At

of

receptors, EL-4 cells w e r e initially treated with increasing

concentrations with

on

P M A d o s e s (10 -8 , Io-TM) the

decrease

in

control

surface

lO 40_

o ~

.~

~

°

I.

"~..

o

°

.o,_

u

.~.

5_

:----_.o\\. ~/

,

0.15

-

\

----..-: ,

,

0.76

3.84

:-------~---~---.~-

19.2

96

~

480

IFN-7 (ng)

Fig. 1. Binding competition curves of 1251_iFN_gamma to EL-4 cel~s, untreated (O-~--O) or treated with increasing concentrations of PMA ( • .... • :10- M; z~.... Z~ :10-8M; • .... • :I0-7M). Each experiment has been repeated at least three times and one representative is reported in the figure. 339

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Vol. 144, No. 1, 1987

o-o Untreated ,-, 10 min. ~ - ~ 3 hours

40-

o

o,2, "o ._= u



\

p,

7'/

,

,

~3

,

064

,

52

16 -

t

,

80

400

IFN- ? (.g)

Fig. 2. Binding competition curves of 125I-IFN-gamma to EL-4 cells, untreated or treated with PMA (10-TM) for increasing times ( • .... • :I0 min; A .... ~ :3 hours; • .... • :overnight). Each experiments has been repeated at least three times and one representative is reported in the figure.

receptors a

r e a c h e d 90%, indicating that loss of I F N - g a m m a receptors is

function

that due

the to

of P M A concentration. T h e s e results,

therefore,

suggest

d e c r e a s e of I F N - g a m m a binding to the EL-4 cells was the receptor down-regulation

by PMA. This h y p o t h e s i s

mainly is

also

s u p p o r t e d by the finding that a m a r k e d increase in the affinity of the remaining receptors (KD 2.8 x 10-10M of P M A - t r e a t e d vs. 1.5 x 10-9M of untreated

cells),

Scatchard

analysis,

inhibition affinity. cells

as

indicated was

by the slope of the

observed, ruling out the

curve

At

Trypan-bleu

all doses tested, moreover, the viability of PMA

treatment

always

exceeded

95%,

as

evaluated at various times

suggesting

short

the

EL-4

judged

by

by

PMA

2). It should be

after 60added

P M A resulted in r e c o v e r y of the I F N - g a m m a binding the

complete

were

after P M A treatment. A 20-30% reduction in

90 min and persisted for several hours(Fig.

shown).

receptor

sites was already detectable at 15 min, it was maximal

of

that

dye exclusion (data not shown).

The kinetics of I F N - g a m m a receptor down-regulation

removal

the

possibility

of IFN binding could be due to a d e c r e a s e in the

after

binding

in

reversibility of the P M A effect

The time c o u r s e of the o b s e r v e d down-regulation

(data

that

sites, not

is relatively

a n d closely follows the activation of proein kinase C (Fassio & 340

Vol. 144, No. 1 , 1 9 8 7

Landolfo, has

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

unpublished

been

identified

observations). Since the major receptor for P M A as the

serine/threonine-specific

Ca2+/phospholipid-dependent

diacylglycerol-activated

protein kinase C

(6), o n e can a r g u e that its activation induces p h o s p h o r y l a t i o n I F N - g a m m a receptor a n d c o n s e q u e n t l y

its down-regulation.

As already mentioned, diacylglycerols activate

protein

replace were

treated

competition occurred diC 8

have been

kinase C (5). To see w h e t h e r

P M A in the d o w n - r e g u l a t i o n

of the

demonstrated

diacylglycerol

of I F N - g a m m a

to

could

receptors, EL-4 cells

with different doses of the synthetic diC 8 a n d u s e d binding experiments. As s h o w n in Fig. 3,

in a d o s e - d e p e n d e n t

in

down-regulation

m a n n e r w h e n increasing concentrations

w e r e added, with the maximal effect occurring at 12.5 ug/ml.

As

s h o w n by Scatchard plot analysis, increase of affinity (KD 8.5 x IO-gM of

diC8-treated

vs. 2 x IO-gM of untreated cells) in

receptors was o b s e r v e d

with

diacylglycer01

to

induce

10

2500

remaining

in accord with the results obtained with PMA.

It has b e e n recently s h o w n that intracellular synergizes

the

~

o~

0.1

~

~2ooo

~

=m "u

mobilization

transferrin

receptor

o

° ~ o

~.

~ o

Ca 2+

"~

..,

" 1500 -~

0.001

°

e~ 1000_ O. (n

I::ls 1

500

/

50

" ~

0.13

0.64

3.2

'16

80

400

IFN-'y (ng)

Fig. 3. Binding competition curves of 1251-1FN-gamma to EL-4 cells, untreated ( O .... O ) or treated with increasing concentrations of dic 8

has

( • ....

been

reported

ZX :6,25 u g / m l ;

repeated in the

• ....



:12,50 u g / m l ) . E a c h e x p e r J . m e n t s

at least three times and

figure. 341

one

representative

is

of

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Vol. 144, No. 1,1987

40_

o--o

o ~

+A23187 (100pM) .... PMA ( ' 0 " 9 M )

o~ 20-

0

untreated

~--~

,~

5-

m.

u)

-7// 0,15

0.76

3.84

19.2

96

480

IFN-'Y (ng) Fig. 4. Binding competition curves of 1251-IFN-gamma to EL-4 cells, untreated ( O .... O ) or treated for three hour~ with A23187 2+

.

Ca -lonophore ( zl.... Z~ : 100pM), P M A ( • .... • :i0- M) or A 2 3 1 8 7 and PMA together. E a c h e x p e r i m e n t h a s b e e n r e p e a t e d at least three t~mes a n d o n e r e p r e s e n t a t i v e is r e p o r t e d in the figure.

down-regulation modulate cells

(15). To

expression

were

treated

ionophore

themselves

as

(about

of

IO-gM

down-regulation. suggest

of

the IFN-gamma

with

increasing

could

receptor in our

concentrations

also

system, of

EL-4

Ca 2+

the

A23187 and used in binding experiments. As shown in Eig. 4,

concentrations

potency

see whether Ca 2+ mobilization

low

as

i00 pM, although not

23% down-regulation), PMA

The

as

a

very

increased

mediator

of

effective

dramatically

IFN-gamma

results obtained with diC 8 and

Ca 2+

the

receptor ionophore

that proein kinase C is involved in this down-regulation

decrease

of

affinity.

phosphatidylinositol

Diacylglycerol,

a

primary

product

in

and

of

metabolism, has, in fact, been shown to bind and

activate protein kinase C (5). Yet the use of Ca2+ionophore A23187 has revealed kinase

an C

Raising increases

apparent synergism between Ca2+mobilization and

activation of

in the down-regulation

intracellular the

Ca 2+,

although

of

membrane

ineffective

by

protein

receptors. itself,

potency of P M A in the activation of protein kinase

phosphorylation

of

down-regulation.

We

transferrin

receptor

and

its subsequent

would therefore suggest that IFN-gamma

342

C,

receptor

Vol. 144, No. 1, 1987

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

EL-4

40

R" O v,-

o-o Untreated * - * PMA (10-7M)

L 1210 ~-~ Untreated , - , PMA (10-7M)

°~o

x

E

20

O. u rO~ "O c

10

\

.D

.u_ U)

i

i

i

0.15

0.76

384

i ""-'-

19.2

ei ' - ' ' -

96

480

IFN-7

0.15

0.76

~84

19.2

96

480

(ng)

Fig. 5. Binding competition curves of 125I-IFN-gamma to EL-~ and LI210 cells untreated or treated for 3 hours with PMA (IO-~M). Each experiment has been repeated at least three times and one representative is reported in the figure.

down-regulation

also o c c u r r e d via protein kinase C activation in

our

system. Since the effect on surface I F N - g a m m a receptor evaluated cells

of

were

as

expression

was

on EL-4 cells, a T i y m p h o m a line, we decided to see w h e t h e r B-lymphocyte-, mcrophage-, fibroblast-, sensitive

to d o w n - r e g u l a t i o n

mastocytoma-origin

by PMA. Our

results

indicate

that these cell lines are m u c h less sensitive. In Fig. 5, a c o m p a r i s o n between indicate protein

EL-4 T-cells a n d LI210 B-cells is shown. therefore kinase

observation although

can

widely

particularly

that

Specificity studies

d o w n regulation of I F N - g a m m a

receptors

C activators is particularly evident on T-cells. be e x p l a i n e d by the finding that protein distributed

in

the tissues

a b u n d a n t in l y m p h o c y t e s

of

many

by

This

kinase

species,

(6). In this connection, it

C, is

may

be m e n t i o n e d that s o m e time ago Kraft et al. (16) f o u n d high levels of protein

kinase C in

EL-4 cells, a n d d e m o n s t r a t e d that P M A induces

a

translocation of protein kinase C from the cytosol to the membrane. Activation of protein kinase C by P M A causes

both

a

or

sn-l,2-diacylglycerols

d e c r e a s e in the affinity of s o m e receptors,

343

such

as

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Vol. 144, No. 1, 1987

insulin

and

such as transferrin (8). Moreover,

receptors be

epidermal growth factor (9,10), and

mediated by h y p e r p h o s p h o r y l a t i o n

protein

kinase

C

(8). Our

1,2-Dioctanoyl-glycerol receptor the

both p h e n o m e n a

of the receptors

demonstration

induce

down-regulation

extend those findings to the I F N - g a m m a

first

time

a

possible

regulation of the I F N - g a m m a

down-regulation

involvement

a p p e a r to

by the activated that

of

of

the

PMA

and

IFN-gamma

system and suggest for

of

protein

by grants from the

Italian

kinase

C

receptor.

ACKNOWLEDGMENTS This w o r k was s u p p o r t e d National

Research

Council (PF'Oncologia' No 85.02161.44, a n d

No 85.00860.52), and from the Ministry of Public Education

PF'CMI'

(40%).

REFERENCES l. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16.

Diamond, L., O'Brien, T., and Rovera, G. (]978) Life Sci. 23, 1979-1988. Rovera, G., Santo/i, D., and Samsky, C. (1979) Proc. Natl. Acad. Sci. USA 76, 2779-2783. Castagna, M., Takui, Y., Kaibuchi, K., Sano, R., Kikkawa, U., and Nishizuka, Y. (1982) J. biol. Chem. 257, 7847-7851. Leach, K.L., James, M.L., and Blumberg, P.M. (1983) Proc. Natl. Acad. Sci. USA 80, 4208-4212. Ganong, B.R., Loomis, C.R., Hannun, Y.A., and Bell, R.M. (1986) Proc. Natl. Acad. Sci. USA 83, 1184-1188. Nishizuka, Y. (]984) Nature (London) 308, 693-697. Farrar, W.L., a n d Ruscetti, F.W. (1986) J. Immunol. 136, 1266-1273. May, W.S., Jacobs, S., and Cuatrecasas, P. (1984) Proc. Natl. Acad. Sci. USA 81, 2016-2020. Thomopoulos, P., Testa, Y., Gourdin, M., Hervy, C., Titeux, M., and Vainchenker, W. (1982) Eur. J. Biochem. 129, 389-393. Shoyab, M., DeLarco, J.E., and Todaro, G.J. (1979) Nature (London) 279, 387-391. Vilcek, J., Gray, P.W., Rinderknecht, E., and Sevastopoulos, C.G. (1985) L y m p h o k i n e s ii, 1-33. Cofano, F., Fassio, A., Cavallo, G., and Landolfo, S. (1986) J. Gen. Virol. 67, 1205-1209. Zoon, K., and Arnheiter, H. (1984) P h a r m a c o l o g y and Therapy, pp. 259-278, P e r g a m o n Press, London. Gray, P.W., and Goeddel, D.V. (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 5842-5846. May, W.S., Sahyoun, N., Wolf, M., and Cuatrecasas, P. (1985) Nature 317, 549-551. Kraft, A.S., Anderson, W.B., Cooper, H.I., and Sando, J.J. (1982) J. biol. Chem. 257, 13193-13196.

344

in